They showed that anti-mesothelin CARs facilitate the delivery of PTX and cytotoxic granules inside nanovesicles to tumor cells, and the anti-PD-L1 CARs on the surface of LipCExo@PTX efficiently reverse the immunosuppressive effect of the tumor microenvironment [129]. The gene discussed is MSLN; the disease is neoplasm.